QSAR study of selective ligands for the thyroid hormone receptor beta

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Pharmacology

Background:

• Thyroid hormone receptor beta 1 (TRbeta1) is a key target for various therapeutic interventions.
• Developing selective ligands with high binding affinity is crucial for effective drug design.
• Existing methods for predicting ligand binding can be time-consuming and resource-intensive.

Purpose of the Study:

• To develop a robust Quantitative Structure-Activity Relationship (QSAR) model for predicting the binding affinity of selective ligands to TRbeta1.
• To identify key molecular descriptors that correlate with TRbeta1 ligand activity.
• To provide a tool for rapid and accurate prediction of binding affinity and guide the design of new TRbeta1 ligands.

Main Methods:

• Calculation of a comprehensive set of molecular descriptors using DRAGON software for 87 selective TRbeta1 ligands.
• Selection of the most relevant structural descriptors using the Genetic Algorithm optimization method.
• Development and rigorous validation of the QSAR model using internal and external validation, Y-randomization, and applicability domain assessment.

Main Results:

• A QSAR model was successfully developed using six significant molecular descriptors.
• The model demonstrated high accuracy and reliability across multiple validation tests, confirming its robustness.
• The developed model effectively predicts the binding affinity of compounds to TRbeta1 within its defined applicability domain.

Conclusions:

• The developed QSAR model is a reliable and efficient tool for predicting TRbeta1 ligand binding affinity.
• The model provides valuable insights into structure-activity relationships, aiding in the rational design of novel TRbeta1 ligands.
• This approach facilitates faster and more accurate drug discovery efforts targeting TRbeta1.